British biomedical science is to get its first watchdog. But even as details of the plan are being finalized, its architects have generated controversy by saying that they would consider accepting funding from the pharmaceutical industry. Critics also fear that the proposed UK Panel for Health and Biomedical Research Integrity — which will operate under the umbrella of Universities UK (UUK) — may lack the teeth to police research properly. Plans to establish the panel should be completed next month at a board meeting of the UUK, which represents most of Britain's higher-education institutes.
展开▼
